The treatment of oropharyngeal candidiasis in HIV-infected patients with oral amphotericin B suspension

AIDS Patient Care and STDs

Volumn 12, Issue 8, 1998, Pages 625-627

  Hood, Stephen ^a   Evans, Jane ^a   Bond, Jeanette ^a   Wilkins, Edmund ^a   Denning, David ^a,b  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; CLOTRIMAZOLE; FLUCONAZOLE; ITRACONAZOLE; NYSTATIN;

ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; OROPHARYNX; THRUSH; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0031659164     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.1998.12.625     Document Type: Article

References (12)

1. Perfect JR, Klotman ME, Gilbert CC, et al. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant patients. J Infect Dis 1992;165:891-897.
2. BSAC Working Party. Review articles. Antifungal chemotherapy in patients with acquired immunodeficiency syndrome. Lancet 1992;340:648-651.
3. Law D, Moore CB, Wardle HM, Ganguli LA, Keaney MGL, Denning DW. High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J Antimicrob Chemother 1994;34:659-668.
4. Law D, Moore CB, Denning DW. Amphotericin B resistance testing of Candida spp.: A comparison of methods. J Antimicrob Chemother 1997;40:109-112.
5. Pons V, Greenspan D, Debruin M, and the Multicenter Group. Therapy for oropharyngeal candidiasis in HIV-infected patients: A randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. J AIDS 1993;6:1311-1316.
6. Powderley WG, Finkelstein DM, Feinberg J, et al., for the NIAID AIDS Clinical Trials group. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced HIV infection. N Engl J Med 1995;332: 700-705.
7. Brookmeyer NH, Hantschke D, Olbricht T, Hengge UA, Goos M. Comparative study of the therapy of Candida oesphagitis in HIV-1 infected patients with fluconazole or amphotericin B and flucytosine. Mycoses 1991;34:83-86.
8. Cartledge JD, Midgley J, Youle M, Gazzard BG. Itraconazole cyclodextrin solution - effective treatment for HIV-related candidosis unresponsive to other azole therapy. J Antimicrob Chemother 1994;33: 1071-1073.
9. Laine L, Rabeneck L. Prospective study of fluconazole suspension for the treatment of oesophageal candidiasis in patients with AIDS. Aliment Pharmacol Ther 1995;9:553-556.
10. Ewing AE. Amphotericin B lozenges in the treatment of oral thrush. Practitioner 1967:199:62-67.
11. Brandell R, Chase SL, Cohn JR. Treatment of oral candidiasis with amphotericin B solution. Clin Pharmacol 1988;7:70-72.
12. Dewsnup DH, Stevens DA. Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole. J Med Vet Mycol 1994;32: 389-393.